Cargando…
Growth inhibition of Friend erythroleukaemia cell tumours in vivo by a synthetic analogue of prostaglandin A: an action independent of natural killer-activity.
Prostaglandins of the A series (PGAs) have been previously shown to inhibit the growth and to stimulate the differentiation of Friend erythroleukaemic cells (FLC) in vitro. In the present report we analysed the effect of PGA treatment in vitro on FLC tumorigenicity, and in vivo on FLC proliferation...
Autores principales: | Marini, S., Palamara, A. T., Garaci, E., Santoro, M. G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971275/ https://www.ncbi.nlm.nih.gov/pubmed/2328205 |
Ejemplares similares
-
Inhibition of Friend erythroleukaemia-cell tumours in vivo by a synthetic analogue of prostaglandin E2.
por: Santoro, M. G., et al.
Publicado: (1979) -
Effect of endogenous and exogenous prostaglandin E on Friend erythroleukaemia cell growth and differentiation.
por: Santoro, M. G., et al.
Publicado: (1979) -
Observations on the “Eclipse Phase” in a Virus-associated Erythroleukaemia of the Chicken
por: Campbell, J. G.
Publicado: (1954) -
BUDR inhibition of post-DMSO-induced erythroleukaemia cell differentiation in vitro.
por: Preisler, H. D.
Publicado: (1976) -
Genome organization and the role of centromeres in evolution of the erythroleukaemia cell line HEL
por: MacKinnon, Ruth N., et al.
Publicado: (2013)